GI Oncology
From the Journals
Fecal Immunochemical Test Performance for CRC Screening Varies Widely
Despite widespread use of FITs for CRC screening, there is limited data to help guide test selection.
From the Journals
Five Key Measures to Ensure a Quality Colonoscopy
The task force identified 15 quality indicators, divided into preprocedure, intraprocedure, and postprocedure.
News
Cold Snare Resection Safe for Large Nonpedunculated Colorectal Polyps
Despite recommendations for its use, the cold snare method appears to be underused in the United States.
Feature
Breakthrough Blood Test for Colorectal Cancer Gets Green Light
The test’s approval could make it more likely that people get screened for and survive the disease.
Conference Coverage
Risk Stratification May Work Well for FIT-Based CRC Screening in Elderly
Fecal immunochemical tests could play a major role in risk stratification, researchers said.
Feature
How Aspirin May Lower Risk for Colorectal Cancer
These new data suggest that aspirin helps activate the immune system, which helps explain its potential chemopreventive effect in CRC.
Conference Coverage
Should ctDNA guide clinical decisions in GI cancers?
Data are maturing for colon cancer and emerging for pancreatic cancer, but experts say more work needs to be done.
Latest News
AI Patient Navigator Helps Re-Engage Underserved Patients After Missed Colonoscopy
The patient-friendly navigator called patients to discuss rescheduling, assess barriers to colonoscopy uptake, offer live transfers to clinical...
Conference Coverage
Colorectal Cancer Is Spiking Among Some Young Americans
Up to one third of early-onset colorectal cancer cases are linked to factors that cannot be changed.
Conference Coverage
Mailed Outreach for CRC Screening Appeals Across Races and Ethnicities
More participants chose colonoscopy above FIT — across all racial and ethnic groups — at 12.1% versus 5.6% overall.
News from the FDA/CDC
FDA OKs First Multitarget Stool RNA Test for CRC Screening
The FDA approval was based on results of the CRC-PREVENT trial.